SlideShare a Scribd company logo
1 of 28
Pharmacokinetics Models
Dr. Nilesh S. Kulkarni
PES Modern college of Pharmacy (For Ladies)
Moshi Pune
Need Of Pharmacokinetic Models
• Drug movement within the body is a complex process.
• To understand the movement of drug in biological system
pharmacokinetic models come under consideration.
• For ease of mathematical equation understanding
pharmacokinetic models are required.
5/27/2020 2
Pharmacokinetic Models
• Model is a hypothetical space bound by an unspecified
membrane across which drugs are transferred in and out.
• Model is a hypothesis that employs mathematical terms to
concisely describe quantitative relationships.
5/27/2020 Nilesh kulkarni 3
Methods For Analysis Of Pharmacokinetic Data
• The two major approaches in the quantitative study of
various kinetic process of drug disposition in body are
1. Model approach
2. Model-independent approach
5/27/2020 Nilesh kulkarni 4
Model Approach
• In this approach, models are used to describe changes in drug
concentration in the body with time.
1 Compartment Model (empirical model)
(a) Mammillary Model
(b) Catenary Model
2 Physiological Model
(a) Perfusion-Limited Model (b) Diffusion-Limited Model
3 Distributed Parameter Model
5/27/2020 Nilesh kulkarni 5
Mammillary model
• Arrangement of compartments in a manner similar to
connection of satellites to a planet
• Central compartment (compartment 1)
• Plasma
• Highly perfused tissues (such as lung, liver
kidney)
• Peripheral compartment (denoted by no. 2,3, etc)
• Other organs
• Elimination occurs from central compartment
5/27/2020 Nilesh kulkarni 6
Mammillary model continuous…
• Movement of drug between compartments is defined by
characteristic first order rate constant denoted by later K.
• The number of rate constant in a particular compartment
model is given by R.
For IV administration R= 2n-1
For extravascular administration R=2n
n= number of compartment
5/27/2020 Nilesh kulkarni 7
Model 1 One-compartment open model, intravenous
bolus administration.
Model 2 One-compartment open model, extravascular
administration.
5/27/2020 Nilesh kulkarni 8
1
K10
1
K10K01
Model 3 Two-compartment open model , intravenous
bolus administration.
Model 4 Two-compartment open model , extravascular
administration.
5/27/2020 9
1 2
K12
K10
1 2
K12
K10
K01
K 21
Model 5 Three-compartment open model, intravenous
administration.
5/27/2020 Nilesh kulkarni 10
2
31
K21K12
K13
K31
K10
5/27/2020 11
2
31
K21
K21
K13
K31
K10
K01
Model 5 Three-compartment open model, extravascular
administration.
Catenary Model
• In this model compartments are joined to one another in a
series.
• This model is rarely used.
5/27/2020 Nilesh kulkarni 12
1
2 3
K01 K12
K21
K23
K32
ADVANTAGES OF COMPARTMENT
MODELING
• It is a simple and flexible approach.
• It gives a visual representation of various rate processes
involved in drug disposition.
• It is important in development of dose regimens.
• Used for comparison of multiple therapeutic agents.
• It show how many rate constant required for describing
these process.
5/27/2020 Nilesh kulkarni 13
DISADVANTAGES OF COMPARTMENT
MODEL
• The compartment and parameters have no relationship with
physiological functions or anatomical structure of the
species.
• Model may vary within population pharmacokinetics.
• This approach is limited to specific drug only.
• Difficulties generally arises when using model to interpret
the differences between results from human and animal
experiments.
• The model is based on curve fitting of plasma
concentration with complex multi-exponential
mathematical equations.
5/27/2020 Nilesh kulkarni 14
Physiological Model
• Also know as physiologically-based pharmacokinetic
models (PB-PK models).
• It describe the drug disposition in terms of realistic
physiological parameters.
• Number of compartments in the model depends upon
the disposition characteristics of drug.
• Organs such as bone that have no drug penetration are
excluded.
• RET (rapidly equilibrating tissue)- lungs, liver, brain, and
kidney.
• SET (slowly equilibrating tissue)- muscles and adipose tisse.
5/27/2020 Nilesh kulkarni 15
LUNG
HEART
GUT LIVER
LIVLIVE
R
KIDNEY
HPT
PPT
VENOUSBLOOD
ARTERISLBLOOD
QLung
QL-QG
QG
QL
QK
QHPT
QPPT
I.V. DOSE
KM
Ke
elimination
elimination
Physiological Model Continuous…
The rate of drug carried to a tissue/organ or tissue drug uptake is
dependent upon two major factors
• Rate of blood flow to the organ
• Tissue/Blood partition coefficient or diffusion coefficient of drug
On this basis physiological model are two type-
Blood flow rate limited models (Perfusion rate-limited model)
Membrane permeation rate limited models (Diffusion-limited model)
5/27/2020 Nilesh kulkarni 17
Perfusion rate-limited model
• This model is based on the assumption that the drug movement
within a body region is much more rapid than its rate of delivery to
that region by the per fusing blood.
• Applicable only for highly membrane permeable drug(s) i.e. low
molecular weight, poorly-Ionized, and high lipophilic drugs.
thiopental, lidocaine
5/27/2020 Nilesh kulkarni 18
Diffusion-limited model
• Model is applicable for highly polar, ionized drugs for
which cell membrane act as a barrier and gradually
permeates it by diffusion.
• Equation for these models are very complicated.
5/27/2020 Nilesh kulkarni 19
Advantages Of Physiological Modeling
• Mathematical treatment is straightforward.
• The model is suitable where tissue drug concentration and
binding are know.
• Data fitting is not required.
• Exact description of drug concentration-time profile in any
organ or tissue can be obtained.
• The influence of altered physiology or pathology on drug
disposition can be easily predicted from changes in various
pharmacokinetic parameter.
5/27/2020 Nilesh kulkarni 20
Disadvantages Of Physiological Modeling
• Obtaining experimental data, which is very exhaustive.
• Prediction of individualized dosing is difficult.
• Number of data point is less than the pharmacokinetic
parameters to be assessed.
5/27/2020 Nilesh kulkarni 21
Distributed Parameter Model
• Analogous to physiological model.
• Designed only for determining Variation in blood flow to
an organ, Variation in drug diffusion in an organ.
• Specifically used for assessing regional differences in
drug concentration in tumors or necrotic tissue.
5/27/2020 Nilesh kulkarni 22
5/27/2020 Nilesh kulkarni 23
NON-COMPARTMENTAL MODEL
• Also know as model-independent-method.
• Based on the assumption that the drugs or metabolites follow
linear kinetics.
• It dose not require the assumption of specific compartment
model.
• Applicable to any compartment model.
• Describe the pharmacokinetics of drug disposition using time
and concentration parameters.
5/27/2020 Nilesh kulkarni 24
5/27/2020 Nilesh kulkarni 25
NON-COMPARTMENTAL MODEL
5/27/2020 Nilesh kulkarni 26
Advantages Of Non-compartmental Model
• Pharmacokinetic parameters can be easily derived.
• A detailed description of drug disposition is not required.
• Applicable for any drug or metabolite which follow first-
order kinetics.
5/27/2020 Nilesh kulkarni 27
Disadvantages Of Non-compartmental Model
• Provide limited information regarding the plasma drug
concentration-time profile.
• This method does not adequately treat non-linear cases.
5/27/2020 Nilesh kulkarni 28

More Related Content

What's hot

Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...PRAJAKTASAWANT33
 
Pulmonary Drug Delivery System (PDDS)
Pulmonary Drug Delivery System (PDDS)Pulmonary Drug Delivery System (PDDS)
Pulmonary Drug Delivery System (PDDS)PRABU12345678
 
Oral controlled drug delivery systems - Various Approaches
Oral controlled drug delivery systems - Various Approaches Oral controlled drug delivery systems - Various Approaches
Oral controlled drug delivery systems - Various Approaches SIVASWAROOP YARASI
 
P h partition hypothesis
P h partition hypothesisP h partition hypothesis
P h partition hypothesisZahid1392
 
IN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATIONIN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATIONN Anusha
 
Rate-Controlled Drug Delivery System
Rate-Controlled Drug Delivery SystemRate-Controlled Drug Delivery System
Rate-Controlled Drug Delivery SystemKailas Mali
 
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolusPharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolusAreej Abu Hanieh
 
Osmotic drug delivery system
Osmotic drug delivery systemOsmotic drug delivery system
Osmotic drug delivery systemDr. Shreeraj Shah
 
In vitro Dissolution Testing Models
In vitro Dissolution Testing ModelsIn vitro Dissolution Testing Models
In vitro Dissolution Testing ModelsAmeer Ahmed
 
Microcapsules: types, preparation and evaluation
Microcapsules: types, preparation and evaluationMicrocapsules: types, preparation and evaluation
Microcapsules: types, preparation and evaluationMOHAMMAD ASIM
 
generic substitution and biowaver
generic substitution and biowavergeneric substitution and biowaver
generic substitution and biowaverSUJITHA MARY
 
formulation of Buccal Drug Delivery System.pptx
formulation of Buccal Drug Delivery System.pptxformulation of Buccal Drug Delivery System.pptx
formulation of Buccal Drug Delivery System.pptxPawanDhamala1
 
Pulmonary drug delivery system.
Pulmonary drug delivery system.Pulmonary drug delivery system.
Pulmonary drug delivery system.Mohammad Imran
 
Compendial methods of dissolution
Compendial methods of dissolutionCompendial methods of dissolution
Compendial methods of dissolutionHemanth KG
 
Computational modelling of drug disposition
Computational modelling of drug disposition Computational modelling of drug disposition
Computational modelling of drug disposition lalitajoshi9
 

What's hot (20)

Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...
 
Pulmonary Drug Delivery System (PDDS)
Pulmonary Drug Delivery System (PDDS)Pulmonary Drug Delivery System (PDDS)
Pulmonary Drug Delivery System (PDDS)
 
Oral controlled drug delivery systems - Various Approaches
Oral controlled drug delivery systems - Various Approaches Oral controlled drug delivery systems - Various Approaches
Oral controlled drug delivery systems - Various Approaches
 
P h partition hypothesis
P h partition hypothesisP h partition hypothesis
P h partition hypothesis
 
Nasal and pulmonary dds
Nasal and pulmonary ddsNasal and pulmonary dds
Nasal and pulmonary dds
 
Quality by Design ( QbD )
Quality by Design ( QbD )Quality by Design ( QbD )
Quality by Design ( QbD )
 
IN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATIONIN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATION
 
Rate-Controlled Drug Delivery System
Rate-Controlled Drug Delivery SystemRate-Controlled Drug Delivery System
Rate-Controlled Drug Delivery System
 
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolusPharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolus
 
Dissolution
DissolutionDissolution
Dissolution
 
Osmotic drug delivery system
Osmotic drug delivery systemOsmotic drug delivery system
Osmotic drug delivery system
 
In vitro Dissolution Testing Models
In vitro Dissolution Testing ModelsIn vitro Dissolution Testing Models
In vitro Dissolution Testing Models
 
Microcapsules: types, preparation and evaluation
Microcapsules: types, preparation and evaluationMicrocapsules: types, preparation and evaluation
Microcapsules: types, preparation and evaluation
 
generic substitution and biowaver
generic substitution and biowavergeneric substitution and biowaver
generic substitution and biowaver
 
formulation of Buccal Drug Delivery System.pptx
formulation of Buccal Drug Delivery System.pptxformulation of Buccal Drug Delivery System.pptx
formulation of Buccal Drug Delivery System.pptx
 
Pulmonary drug delivery system.
Pulmonary drug delivery system.Pulmonary drug delivery system.
Pulmonary drug delivery system.
 
Qbd
QbdQbd
Qbd
 
Supac
SupacSupac
Supac
 
Compendial methods of dissolution
Compendial methods of dissolutionCompendial methods of dissolution
Compendial methods of dissolution
 
Computational modelling of drug disposition
Computational modelling of drug disposition Computational modelling of drug disposition
Computational modelling of drug disposition
 

Similar to Chapter 9 introduction to pharmacokinetic model [compatibility mode]

Presentation on pharmacokinetic model by pallavi
Presentation on pharmacokinetic model by pallaviPresentation on pharmacokinetic model by pallavi
Presentation on pharmacokinetic model by pallaviPallavi Chalana
 
Compartment modeling ppt
Compartment modeling pptCompartment modeling ppt
Compartment modeling pptbinu anand
 
1. Int-Phk-Rate- Model-ADME.pptx
1. Int-Phk-Rate- Model-ADME.pptx1. Int-Phk-Rate- Model-ADME.pptx
1. Int-Phk-Rate- Model-ADME.pptxjiregna5
 
Pharmacokinetic models(biopharmaceutics)
Pharmacokinetic models(biopharmaceutics)Pharmacokinetic models(biopharmaceutics)
Pharmacokinetic models(biopharmaceutics)MdIrfanUddin2
 
Lecture 8.pdf
Lecture 8.pdfLecture 8.pdf
Lecture 8.pdfrehanrustam1
 
PK. introduction.ppt
PK. introduction.pptPK. introduction.ppt
PK. introduction.pptAsmaaRadwan6
 
GIT Absorption Simulation
GIT Absorption SimulationGIT Absorption Simulation
GIT Absorption SimulationJaskiranKaur72
 
Pharma co kinetics compartmental modeling
Pharma co kinetics compartmental modeling Pharma co kinetics compartmental modeling
Pharma co kinetics compartmental modeling Manjit Kaur
 
Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...
Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...
Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...bhupenkalita7
 
ORGANS-ON-CHIPS
ORGANS-ON-CHIPSORGANS-ON-CHIPS
ORGANS-ON-CHIPSELMAHDIJUEID
 
COMPUTATIONAL MODELING IN DRUG DISPOSITION.pptx
COMPUTATIONAL MODELING IN DRUG DISPOSITION.pptxCOMPUTATIONAL MODELING IN DRUG DISPOSITION.pptx
COMPUTATIONAL MODELING IN DRUG DISPOSITION.pptxMohammad Azhar
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
Computational modeling of drug disposition
Computational modeling of drug dispositionComputational modeling of drug disposition
Computational modeling of drug dispositionArman Dalal
 
GASTROINTESTINAL ABSORPTION SIMULATION CADD.pptx
GASTROINTESTINAL ABSORPTION SIMULATION CADD.pptxGASTROINTESTINAL ABSORPTION SIMULATION CADD.pptx
GASTROINTESTINAL ABSORPTION SIMULATION CADD.pptxMittalGandhi
 
Pharmacokinetic analysis of mathematical data - Pharmacokinetic models
Pharmacokinetic analysis of mathematical data - Pharmacokinetic modelsPharmacokinetic analysis of mathematical data - Pharmacokinetic models
Pharmacokinetic analysis of mathematical data - Pharmacokinetic modelsJyotsana Bhatt
 

Similar to Chapter 9 introduction to pharmacokinetic model [compatibility mode] (20)

Presentation on pharmacokinetic model by pallavi
Presentation on pharmacokinetic model by pallaviPresentation on pharmacokinetic model by pallavi
Presentation on pharmacokinetic model by pallavi
 
PHARMACOKINETIC MODELS
PHARMACOKINETIC MODELSPHARMACOKINETIC MODELS
PHARMACOKINETIC MODELS
 
PHARMACOKINETIC MODEL
PHARMACOKINETIC MODELPHARMACOKINETIC MODEL
PHARMACOKINETIC MODEL
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Compartment modeling ppt
Compartment modeling pptCompartment modeling ppt
Compartment modeling ppt
 
1. Int-Phk-Rate- Model-ADME.pptx
1. Int-Phk-Rate- Model-ADME.pptx1. Int-Phk-Rate- Model-ADME.pptx
1. Int-Phk-Rate- Model-ADME.pptx
 
Pharmacokinetic models(biopharmaceutics)
Pharmacokinetic models(biopharmaceutics)Pharmacokinetic models(biopharmaceutics)
Pharmacokinetic models(biopharmaceutics)
 
Lecture 8.pdf
Lecture 8.pdfLecture 8.pdf
Lecture 8.pdf
 
PK. introduction.ppt
PK. introduction.pptPK. introduction.ppt
PK. introduction.ppt
 
GIT Absorption Simulation
GIT Absorption SimulationGIT Absorption Simulation
GIT Absorption Simulation
 
Pharma co kinetics compartmental modeling
Pharma co kinetics compartmental modeling Pharma co kinetics compartmental modeling
Pharma co kinetics compartmental modeling
 
Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...
Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...
Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...
 
Pharmacokinetic models
Pharmacokinetic  modelsPharmacokinetic  models
Pharmacokinetic models
 
ORGANS-ON-CHIPS
ORGANS-ON-CHIPSORGANS-ON-CHIPS
ORGANS-ON-CHIPS
 
COMPUTATIONAL MODELING IN DRUG DISPOSITION.pptx
COMPUTATIONAL MODELING IN DRUG DISPOSITION.pptxCOMPUTATIONAL MODELING IN DRUG DISPOSITION.pptx
COMPUTATIONAL MODELING IN DRUG DISPOSITION.pptx
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
Clinical pharmacokinetics
Clinical pharmacokineticsClinical pharmacokinetics
Clinical pharmacokinetics
 
Computational modeling of drug disposition
Computational modeling of drug dispositionComputational modeling of drug disposition
Computational modeling of drug disposition
 
GASTROINTESTINAL ABSORPTION SIMULATION CADD.pptx
GASTROINTESTINAL ABSORPTION SIMULATION CADD.pptxGASTROINTESTINAL ABSORPTION SIMULATION CADD.pptx
GASTROINTESTINAL ABSORPTION SIMULATION CADD.pptx
 
Pharmacokinetic analysis of mathematical data - Pharmacokinetic models
Pharmacokinetic analysis of mathematical data - Pharmacokinetic modelsPharmacokinetic analysis of mathematical data - Pharmacokinetic models
Pharmacokinetic analysis of mathematical data - Pharmacokinetic models
 

More from Nilesh Kulkarni

Solubility estimation
Solubility estimation Solubility estimation
Solubility estimation Nilesh Kulkarni
 
Factors affecting metabolism of drug
Factors affecting metabolism of drugFactors affecting metabolism of drug
Factors affecting metabolism of drugNilesh Kulkarni
 
Factors affecting drug absorption part iii
Factors affecting drug absorption part iiiFactors affecting drug absorption part iii
Factors affecting drug absorption part iiiNilesh Kulkarni
 
Factors affecting drug absorption part ii
Factors affecting drug absorption part iiFactors affecting drug absorption part ii
Factors affecting drug absorption part iiNilesh Kulkarni
 
Absorption of drug
Absorption of drugAbsorption of drug
Absorption of drugNilesh Kulkarni
 
In Vitro In vivo Correlation
In Vitro In vivo CorrelationIn Vitro In vivo Correlation
In Vitro In vivo CorrelationNilesh Kulkarni
 
Hair structure and hair growth cycle
Hair structure and hair growth cycleHair structure and hair growth cycle
Hair structure and hair growth cycleNilesh Kulkarni
 
12 Drug Distribution part 2
12 Drug Distribution part 212 Drug Distribution part 2
12 Drug Distribution part 2Nilesh Kulkarni
 
Bioavailability and Bioequivalence
Bioavailability and Bioequivalence Bioavailability and Bioequivalence
Bioavailability and Bioequivalence Nilesh Kulkarni
 
Distribution of drug part i
Distribution of drug part iDistribution of drug part i
Distribution of drug part iNilesh Kulkarni
 

More from Nilesh Kulkarni (13)

Solubility estimation
Solubility estimation Solubility estimation
Solubility estimation
 
Factors affecting metabolism of drug
Factors affecting metabolism of drugFactors affecting metabolism of drug
Factors affecting metabolism of drug
 
Factors affecting drug absorption part iii
Factors affecting drug absorption part iiiFactors affecting drug absorption part iii
Factors affecting drug absorption part iii
 
Factors affecting drug absorption part ii
Factors affecting drug absorption part iiFactors affecting drug absorption part ii
Factors affecting drug absorption part ii
 
Metabolism part i
Metabolism part iMetabolism part i
Metabolism part i
 
Absorption of drug
Absorption of drugAbsorption of drug
Absorption of drug
 
In Vitro In vivo Correlation
In Vitro In vivo CorrelationIn Vitro In vivo Correlation
In Vitro In vivo Correlation
 
Hair colorant
Hair colorantHair colorant
Hair colorant
 
Hair structure and hair growth cycle
Hair structure and hair growth cycleHair structure and hair growth cycle
Hair structure and hair growth cycle
 
12 Drug Distribution part 2
12 Drug Distribution part 212 Drug Distribution part 2
12 Drug Distribution part 2
 
Dissolution
DissolutionDissolution
Dissolution
 
Bioavailability and Bioequivalence
Bioavailability and Bioequivalence Bioavailability and Bioequivalence
Bioavailability and Bioequivalence
 
Distribution of drug part i
Distribution of drug part iDistribution of drug part i
Distribution of drug part i
 

Recently uploaded

URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docxPoojaSen20
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 

Recently uploaded (20)

URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docx
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 

Chapter 9 introduction to pharmacokinetic model [compatibility mode]

  • 1. Pharmacokinetics Models Dr. Nilesh S. Kulkarni PES Modern college of Pharmacy (For Ladies) Moshi Pune
  • 2. Need Of Pharmacokinetic Models • Drug movement within the body is a complex process. • To understand the movement of drug in biological system pharmacokinetic models come under consideration. • For ease of mathematical equation understanding pharmacokinetic models are required. 5/27/2020 2
  • 3. Pharmacokinetic Models • Model is a hypothetical space bound by an unspecified membrane across which drugs are transferred in and out. • Model is a hypothesis that employs mathematical terms to concisely describe quantitative relationships. 5/27/2020 Nilesh kulkarni 3
  • 4. Methods For Analysis Of Pharmacokinetic Data • The two major approaches in the quantitative study of various kinetic process of drug disposition in body are 1. Model approach 2. Model-independent approach 5/27/2020 Nilesh kulkarni 4
  • 5. Model Approach • In this approach, models are used to describe changes in drug concentration in the body with time. 1 Compartment Model (empirical model) (a) Mammillary Model (b) Catenary Model 2 Physiological Model (a) Perfusion-Limited Model (b) Diffusion-Limited Model 3 Distributed Parameter Model 5/27/2020 Nilesh kulkarni 5
  • 6. Mammillary model • Arrangement of compartments in a manner similar to connection of satellites to a planet • Central compartment (compartment 1) • Plasma • Highly perfused tissues (such as lung, liver kidney) • Peripheral compartment (denoted by no. 2,3, etc) • Other organs • Elimination occurs from central compartment 5/27/2020 Nilesh kulkarni 6
  • 7. Mammillary model continuous… • Movement of drug between compartments is defined by characteristic first order rate constant denoted by later K. • The number of rate constant in a particular compartment model is given by R. For IV administration R= 2n-1 For extravascular administration R=2n n= number of compartment 5/27/2020 Nilesh kulkarni 7
  • 8. Model 1 One-compartment open model, intravenous bolus administration. Model 2 One-compartment open model, extravascular administration. 5/27/2020 Nilesh kulkarni 8 1 K10 1 K10K01
  • 9. Model 3 Two-compartment open model , intravenous bolus administration. Model 4 Two-compartment open model , extravascular administration. 5/27/2020 9 1 2 K12 K10 1 2 K12 K10 K01 K 21
  • 10. Model 5 Three-compartment open model, intravenous administration. 5/27/2020 Nilesh kulkarni 10 2 31 K21K12 K13 K31 K10
  • 11. 5/27/2020 11 2 31 K21 K21 K13 K31 K10 K01 Model 5 Three-compartment open model, extravascular administration.
  • 12. Catenary Model • In this model compartments are joined to one another in a series. • This model is rarely used. 5/27/2020 Nilesh kulkarni 12 1 2 3 K01 K12 K21 K23 K32
  • 13. ADVANTAGES OF COMPARTMENT MODELING • It is a simple and flexible approach. • It gives a visual representation of various rate processes involved in drug disposition. • It is important in development of dose regimens. • Used for comparison of multiple therapeutic agents. • It show how many rate constant required for describing these process. 5/27/2020 Nilesh kulkarni 13
  • 14. DISADVANTAGES OF COMPARTMENT MODEL • The compartment and parameters have no relationship with physiological functions or anatomical structure of the species. • Model may vary within population pharmacokinetics. • This approach is limited to specific drug only. • Difficulties generally arises when using model to interpret the differences between results from human and animal experiments. • The model is based on curve fitting of plasma concentration with complex multi-exponential mathematical equations. 5/27/2020 Nilesh kulkarni 14
  • 15. Physiological Model • Also know as physiologically-based pharmacokinetic models (PB-PK models). • It describe the drug disposition in terms of realistic physiological parameters. • Number of compartments in the model depends upon the disposition characteristics of drug. • Organs such as bone that have no drug penetration are excluded. • RET (rapidly equilibrating tissue)- lungs, liver, brain, and kidney. • SET (slowly equilibrating tissue)- muscles and adipose tisse. 5/27/2020 Nilesh kulkarni 15
  • 17. Physiological Model Continuous… The rate of drug carried to a tissue/organ or tissue drug uptake is dependent upon two major factors • Rate of blood flow to the organ • Tissue/Blood partition coefficient or diffusion coefficient of drug On this basis physiological model are two type- Blood flow rate limited models (Perfusion rate-limited model) Membrane permeation rate limited models (Diffusion-limited model) 5/27/2020 Nilesh kulkarni 17
  • 18. Perfusion rate-limited model • This model is based on the assumption that the drug movement within a body region is much more rapid than its rate of delivery to that region by the per fusing blood. • Applicable only for highly membrane permeable drug(s) i.e. low molecular weight, poorly-Ionized, and high lipophilic drugs. thiopental, lidocaine 5/27/2020 Nilesh kulkarni 18
  • 19. Diffusion-limited model • Model is applicable for highly polar, ionized drugs for which cell membrane act as a barrier and gradually permeates it by diffusion. • Equation for these models are very complicated. 5/27/2020 Nilesh kulkarni 19
  • 20. Advantages Of Physiological Modeling • Mathematical treatment is straightforward. • The model is suitable where tissue drug concentration and binding are know. • Data fitting is not required. • Exact description of drug concentration-time profile in any organ or tissue can be obtained. • The influence of altered physiology or pathology on drug disposition can be easily predicted from changes in various pharmacokinetic parameter. 5/27/2020 Nilesh kulkarni 20
  • 21. Disadvantages Of Physiological Modeling • Obtaining experimental data, which is very exhaustive. • Prediction of individualized dosing is difficult. • Number of data point is less than the pharmacokinetic parameters to be assessed. 5/27/2020 Nilesh kulkarni 21
  • 22. Distributed Parameter Model • Analogous to physiological model. • Designed only for determining Variation in blood flow to an organ, Variation in drug diffusion in an organ. • Specifically used for assessing regional differences in drug concentration in tumors or necrotic tissue. 5/27/2020 Nilesh kulkarni 22
  • 24. NON-COMPARTMENTAL MODEL • Also know as model-independent-method. • Based on the assumption that the drugs or metabolites follow linear kinetics. • It dose not require the assumption of specific compartment model. • Applicable to any compartment model. • Describe the pharmacokinetics of drug disposition using time and concentration parameters. 5/27/2020 Nilesh kulkarni 24
  • 25. 5/27/2020 Nilesh kulkarni 25 NON-COMPARTMENTAL MODEL
  • 27. Advantages Of Non-compartmental Model • Pharmacokinetic parameters can be easily derived. • A detailed description of drug disposition is not required. • Applicable for any drug or metabolite which follow first- order kinetics. 5/27/2020 Nilesh kulkarni 27
  • 28. Disadvantages Of Non-compartmental Model • Provide limited information regarding the plasma drug concentration-time profile. • This method does not adequately treat non-linear cases. 5/27/2020 Nilesh kulkarni 28